The Hereditary Disease Foundation accepts Letters of Intent (LOIs) for grants every year. HDF provides funding to researchers to advance the discovery and development of treatments for Huntington's disease and other brain diseases. The Hereditary Disease Foundation Research Grants provide more experienced researchers with seed funding to enable them to collect the preliminary data needed to obtain major, long-term funding from other organizations, including the National Institutes of Health. The Hereditary Disease Foundation gives highest priority to funding investigators with the most innovative and impactful proposals to advance Huntington's disease research and therapeutics. Moreover, HDF gives priority to the early career stage investigators, including postdoctoral fellows, who are committed to a career in HD research. The Hereditary Disease Foundation funds applications for grants for researchers working in laboratories around the world. Applicants must submit their Letter of Intent from July 15, 2025 - September 3, 2025. Submission of full application will be from October 17, 2025 - December 2, 2025. Please visit the award's website for more information.